|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.31 USD | -1.05% |
|
-1.21% | +20.92% |
EPS & Dividend: Revolution Medicines, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.01 | -2.57 | -3.08 | -3.86 | -3.58 | -5.586 | -6.532 | -5.656 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 39.59 | 25.17 | 23.82 | 28.68 | 43.74 | 96.31 | 96.31 | 96.31 |
| Nbr of stocks (in thousands) | 66,380 | 73,687 | 88,791 | 164,565 | 184,795 | 193,320 | 193,320 | - |
| Announcement Date | 02/03/21 | 28/02/22 | 27/02/23 | 26/02/24 | 26/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Revolution Medicines, Inc.
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -17.24x | 11.73x | 4584.51x | |
| 0.94% | 1.04% | 36.46x | 3.73x | 5.29x | |
| -.--% | -.--% | 106.75x | 9.58x | 6.78x | |
| 0.3% | 0.3% | 63.2x | 3.02x | 12.9x | |
| -.--% | -.--% | 23.6x | 4.48x | 2.57x | |
| - | - | - | - | - | |
| 0.97% | 1.14% | 25.15x | 2.24x | 2.07x | |
| -.--% | -.--% | 39.12x | 146.99x | 7.56x | |
| -.--% | -.--% | -35.61x | 47.41x | 13.49x | |
| -.--% | -.--% | 25.14x | 12.48x | 3.97x | |
| Average | 0.25% | 0.28% | 29.62x | 26.85x | 515.46x | |
| Weighted average by Cap. | 0.31% | 0.34% | 41.41x | 16.96x | 392.34x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition